|
INMB INmune Bio Inc 1711754 |
| Balance Sheet |
|
Current Assets
|
$22,822,000.00 |
|
Assets
|
$25,818,000.00 |
|
Current Liabilities
|
$5,388,000.00 |
|
Liabilities
|
$6,194,000.00 |
|
Equity
|
$19,624,000.00 |
|
Shares Out
|
26585258.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,403,000.00 |
|
Investing Cash Flow
|
$-1,042,000.00 |
| Market Analysis |
Market Cap
|
$47,055,906.66 |
|
Price
|
$1.77 |
|
BVPS
|
0.74 |
|
PB
|
2.39 |
|
EPS
|
-0.20 |
|
PS
|
903.90 |
|
FCF
|
$-4,445,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:41 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:41 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-1.86 |
|
|
2026-05-07 |
-0.20 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-1.05 |
|
| Oct |
Nov |
Dec |
|
|
2025-10-30 |
-0.24 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view INMB documents filed with the SEC.
INMB Filings
Clear
